Jeff Horsch
About Jeff Horsch
Jeff Horsch is the Associate Director of Global Quality Risk Management at Bristol Myers Squibb, with over 20 years of experience in the pharmaceutical and biotechnology industries.
Title
Jeff Horsch currently holds the position of Associate Director, Global Quality Risk Management at Bristol Myers Squibb. In this role, he is based in New Brunswick, New Jersey, in the United States.
Current Role at Bristol Myers Squibb
Jeff Horsch serves as the Associate Director, Global Quality Risk Management at Bristol Myers Squibb. Located in New Brunswick, New Jersey, he focuses on overseeing quality risk management strategies and initiatives on a global scale.
Career Progression at Bristol Myers Squibb
Jeff Horsch has held multiple roles at Bristol Myers Squibb. Before his current position, he served as QA Compliance Manager from 2018 to 2021, and prior to that, he worked as a Senior Microbiologist from 2014 to 2018. Each role has been based in New Brunswick, New Jersey.
Quality Control Management at Genzyme
Between 2010 and 2014, Jeff Horsch worked at Genzyme, a Sanofi company, as Quality Control Manager. During his tenure in Ridgefield, New Jersey, he managed quality control processes to ensure compliance and quality across operations.
Experience at ImClone Systems
Jeff Horsch spent several years at ImClone Systems, a wholly-owned subsidiary of Eli Lilly and Company. He served as QC Supervisor from 2006 to 2010 and as QC Senior Analyst/QC Analyst II from 2004 to 2006, both roles based in Branchburg, New Jersey.
Microbiologist at GSK
Jeff Horsch began his career as a Microbiologist at GSK, working in Piscataway, New Jersey, from 2002 to 2004. His responsibilities included microbiological analysis and ensuring adherence to quality standards.
Education and Expertise
Jeff Horsch holds a Master’s Degree in Quality Assurance and Regulatory Affairs from Temple University, achieved between 2005 and 2008. Prior to this, he earned a Bachelor’s Degree in Biology from Drew University, where he studied from 1998 to 2002. His education has equipped him with deep knowledge and specialized skills in quality risk management and compliance in the pharmaceutical industry.